

News
In the news

17/06/2022
SomaLogic, OncoHost announce license agreement for the development of precision cancer diagnostics
Original source here
SomaLogic and OncoHost signed a licensing agreement, through which OncoHost will license SomaLogic’s SomaScan Platform to develop proteomics tests for its PROphet diagnostic system, designed to predict patients’ response to immunotherapy treatments and provide strategies to overcome treatment resistance.